Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Dec;15(3):179-86.
doi: 10.3904/kjim.2000.15.3.179.

Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding

Affiliations

Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding

S W Han et al. Korean J Intern Med. 2000 Dec.

Abstract

Background: Transjugular intrahepatic portosystemic shunt (TIPS) has been popularized for the treatment of refractory variceal bleeding. The aim of this study was to assess the safety and long-term effect of TIPS in the treatment of variceal bleeding that is not controlled with pharmacological and endoscopic treatment.

Methods: Thirty-six patients who underwent transjugular intrahepatic portosystemic shunt (TIPS) due to refractory variceal bleeding were included in the study. The effectiveness of portal decompression and bleeding control was evaluated. Upper gastrointestinal endoscopy was performed to analyse the degree of varices and portal hypertensive gastropathy (PHG) before TIPS procedure and one to three weeks after TIPS. Angiography was performed in surviving patients, if bleeding recurred, or if ultrasonography or endoscopy suggested stent dysfunction.

Results: TIPS were successfully placed in 36 of 38 patients (94.6%). TIPS achieved hemostasis of variceal bleeding in 34 patients (94.4%). Portal venous pressure decreased from an initial average of 28.7 +/- 7.9 to 23.2 +/- 9.4 mmHg after TIPS (p < 0.05). The portosystemic pressure gradient was significantly decreased from 15.5 +/- 6.3 to 7.8 +/- 4.1 mmHg (p < 0.01). The degree of esophagogastric varices and PHG was significantly improved after TIPS. The total length of follow-up was from one day to 54 months (mean: 355 days). The actuarial probability of survival was 83% at one year and 74% at two years. Overall, 16 episodes of stent dysfunction were diagnosed during follow-up. Stent revision by means of angioplasty was successfully performed in 14 of these episodes.

Conclusion: TIPS is an effective and reliable nonoperative means of lowering portal pressure. This procedure has proved useful in the management of acute variceal bleeding refractory to endoscopic treatment. Surveillance by ultrasonography, endoscopy, and angiographic intervention is useful for the maintenance of shunt patency.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Pressure changes after TIPS. PVP, portal venous pressure; HVP, hepatic venous pressure; PSG, portosystemic pressure gradient
Figure 2.
Figure 2.
Changes of endoscopic findings after TIPS. EV; esophageal varices, GV; gastric varices, PHG; portal hypertensive gastropathy
Figure 3.
Figure 3.
Kaplan-Meier analysis of patient survival after TIPS. The actuarial probability of survival was 83.0% at one year and 73.8% at two years.
Figure 4.
Figure 4.
Cumulative probability of patients free of rebleeding
Figure 5.
Figure 5.
Kaplan-Meier analysis of patient survival after TIPS by hepatic encephalopathy. The presence of hepatic encephalopathy after TIPS, either aggravated status or newly developed encephalopathy, was not a significant predictive factor for survival (p=0.9891). Group A, patients without newly developed or worsening hepatic encephaopathy after TIPS; Group B, patients with newly developed or worsening hepatic encephalopathy after TIPS

References

    1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800–809. - PubMed
    1. Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J. 1981;282:263–266. - PMC - PubMed
    1. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–354. - PubMed
    1. de Dombal FT, Clarke JR, Clamp SE, Malizia G, Kotwal MR, Morgan AG. Prognostic factors in upper G.I. bleeding. Endoscopy. 1986;18(Suppl 2):6–10. - PubMed
    1. Cello JP, Grendell JH, Crass RA, Trunkey DD, Cobb EE, Heilbron DC. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984;311:1589–1594. - PubMed